Hyper Corporation Inc. (KOSDAQ:065650)
South Korea flag South Korea · Delayed Price · Currency is KRW
4,355.00
+270.00 (6.61%)
At close: Aug 6, 2025, 3:30 PM KST

Hyper Corporation Company Description

Hyper Corporation Inc., a clinical stage biopharmaceutical company, focuses on the development of Alzheimer's disease (AD) and neuropathic pain treatments, and AD diagnostics.

Its products under development include TRPV1 Antagonist and TRPV1 Agonist for neuropathic pain; and anti-oligomerization of beta-amyloid, receptor for advanced glycation endproduct modulator, and early diagnosis kits for AD.

The company wholesales and retails electronic devices, small home appliances, TVs, routers, and PC peripherals, such as gaming monitors, mouse, and wheels; keyboards; headsets; webcams; and sound bars, as well as provides online contents.

In addition, it manufactures and supplies frozen and room temperature convenience food products, such as frozen sticky rice and fish cakes, tteokbokki sauce, and raw materials for sauce under the Memories of Elementary School Tteokbokki, Newtro, and K-TOWN brands.

The company was formerly known as Medifron DBT Co., Ltd. and changed its name to Hyper Corporation Inc. in March 2024.

Hyper Corporation Inc. was founded in 1997 and is headquartered in Seoul, South Korea.

Hyper Corporation Inc.
CountrySouth Korea
Founded1997
IndustryComputer Programming, Data Processing, And Other Computer Related Services
Employees46

Contact Details

Address:
Cykan Holdings Tower
Seoul
South Korea
Websitehyper-corp.com

Stock Details

Ticker Symbol065650
ExchangeKOSDAQ
Stock TypeCommon Stock
Fiscal YearJanuary - December
Reporting CurrencyKRW
SIC Code7370